Therefore, ameliorating glucose and lipid metabolism via regulating IRS-1/2, PPAR-α, and PPAR-γ may be one of the major mechanisms of BS on NAFLD. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.